Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Di, US

Jia Di, Fayetteville, AR US

Patent application numberDescriptionPublished
20110032000ULTRA-LOW POWER MULTI-THRESHOLD ASYNCHRONOUS CIRCUIT DESIGN - A Multi-Threshold CMOS NULL Convention Logic asynchronous circuit (MTNCL). The MTNCL circuit provides delay-insensitive logic operation with significant leakage power and active energy reduction. The MTNCL circuit is also capable of functioning properly under extreme supply voltage scaling down to the sub-threshold region for further power reduction. Four MTNCL architectures and four MTNCL threshold gate designs offer an asynchronous logic design methodology for glitch-free, ultra-low power, and faster circuits without area overhead.02-10-2011

Jianbo Di, Evansville, IN US

Patent application numberDescriptionPublished
20090012199Photoinitiator anchored to silicate and use thereof to prepare polymer exfolidated silicate nanocomposite - Photoinitiator modified silicate and ethylenically unsaturated monomer are reacted in solvent to cause living polymerization of monomer and exfoliation of silicate layers and cause attachment of silicate layers to polymer chains, thereby providing dispersed homopolymer or block copolymer silicate nanocomposites.01-08-2009
20090018229Nanocomposites prepared using nanoadditive containing dispersed silicate layers or inorganic nanoparticles - Nanocomposites of silicate layers or inorganic nanoparticles dispersed in a polymer or copolymer matrix are prepared by solution blending or melt blending the polymer or copolymer with nanoadditive containing from 20 to 50 weight percent silicate layers or inorganic nanoparticles dispersed in a different polymer or copolymer of M01-15-2009
20090030174One-pot, one-step in situ living polymerization from silicate anchored multifunctional initiator - Silicate anchored multifunctional initiator has moiety initiating ring opening living polymerization of lactone or ethylene oxide or cyclic siloxane monomer and other moiety for initiating living free radical polymerization of ethylenically unsaturated monomer. The monomers are reacted with the initiator in a one-pot, one-step reaction to cause living polymerization of both monomers and exfoliation of silicate layers to provide dispersed block copolymer silicate nanocomposite, with the junction of the two blocks being anchored to silicate layer and each block dangling therefrom.01-29-2009

Patent applications by Jianbo Di, Evansville, IN US

Jianbo Di, Palatine, IL US

Patent application numberDescriptionPublished
20100189509GEOTECHNICAL APPLICATIONS OF IMPROVED NANOCOMPOSITES - The apparatuses, compositions and methods described herein generally relate to a new application for and formulation of composite-polymer composition. This composition is a nanocomposite, comprising a polymer and a clay, preferably a recycled polymer and a nanoclay. The nanocomposite composition has improved performance characteristics, such as lower creep values and lower coefficients of linear thermal expansion, and can reduce the dependency of plastic product manufacturing on virgin (unrecycled) polymers. Moreover, the nanocomposite is formed into geosynthetic materials, e.g., geomembranes, and storm water retention/detention systems.07-29-2010

Jie Di, Chapel Hill, NC US

Patent application numberDescriptionPublished
20090068243Novel formulations for delivery of antiviral peptide therapeutics - Provided herein are compositions and methods for their administration as therapeutic agents. In particular, provided herein are compositions and their use for the administration of antiviral peptide therapeutics.03-12-2009

Li Di, West Windsor, NJ US

Patent application numberDescriptionPublished
201000619823-SUBSTITUTED-1H-INDOLE, 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES - The invention relates to 3-substituted-1H-indole, 3-substituted-1H-pyrrolo[2,3-b]pyridine, and 3-substituted-1H-pyrrolo[3,2-b]pyridine compounds of the Formula 1:03-11-2010

Qian Di, Ellicott City, MD US

Patent application numberDescriptionPublished
20100106171TRANSCAVAL MESENTERIC VENOUS ANASTOMOSIS AND ACCESS SYSTEM - Disclosed is a system for creating an anastomosis between the inferior vena cava (IVC) and the mesenteric portal vein. The system includes an anastomosis device and a catheter. The anastomosis device brings the IVC and the portal vein into apposition. The resulting anastomosis enables treatment for portal hypertension as well as provides repeated and easy access to the portal system for direct delivery of therapeutic agents to portal organs. The anastomosis device has a proximal flange part, a distal flange part, a flow lumen between them. The proximal and distal flange parts include a plurality of radial struts. A valve part is disposed on one or both of the proximal and distal flange parts. The anastomosis device is made of a memory shape material. The catheter contains a collapsed anastomosis device for insertion and has one or more RF antennas to make the catheter visible under MRI guidance.04-29-2010

Rong Di, East Brunswick, NJ US

Patent application numberDescriptionPublished
20100120680METHOD OF TREATING HEPATITIS C VIRUS - A method of treating or inhibiting hepatitic C virus (HCV). The method comprises administering an effective amount of at least one pokeweed antiviral protein (PAP) mutant alone or in combination with other anti-HCV agents.05-13-2010
20100146667Transgenic plants expressing L3 delta proteins are resistant to trichothecene fungal toxins - Disclosed are specific mutants of L3 and transgenic plants that produce them. The plants exhibit increased resistance to fungal toxins that target ribosomal L3 protein. Also disclosed are transgenic plants that co-produce L3 mutant and an RIP protein, and exhibit increased resistance to various fungal toxins and viruses, while reducing toxicity normally associated with production of the RIP. Uses of the L3 mutants in animals are further disclosed.06-10-2010
20100298238NONTOXIC SHIGA-LIKE TOXIN MUTANT COMPOSITIONS AND METHODS - Disclosed are nontoxic mutants of Shiga-like toxin (Stx1 or Stx2), nucleic acids encoding them, compositions containing the mutants and methods of using the mutants in connection with hemolytic euremic syndrome (HUS). Also disclosed are methods of treating HUS using L3 protein fragments, the nontoxic Stx1 or Stx2 mutants, or combinations thereof.11-25-2010

Xiaojun Di, Cupertino, CA US

Patent application numberDescriptionPublished
20110160092Methods for Selecting a Collection of Single Nucleotide Polymorphisms - The invention relates to the selection of a collection of relevant single nucleotide polymorphisms across a genome to design a nucleic acid probe array. As such, the invention relates to diverse fields impacted by the nature of genetics, including biology, medicine, and medical diagnostics.06-30-2011